Top-News

Essa Pharma Aktie News

Aktie
WKN:  A2JKQ4 ISIN:  CA29668H7085 US-Symbol:  EPIX Branche:  Biotechnologie Land:  Kanada
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Marktkapitalisierung *
7,66 Mio. €
Streubesitz
20,68%
KGV
-
Dividende
1,69 $
Index-Zuordnung
-

Essa Pharma News

25.02.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIX
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIX PR Newswire
25.02.25 - PR Newswire
Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EPIX
Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EPIX PR Newswire
24.02.25 - PR Newswire
Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX
Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX PR Newswire
22.02.25 - PR Newswire
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit PR Newswire
21.02.25 - PR Newswire
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX ...
20.02.25 - PR Newswire
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX PR Newswire
20.02.25 - PR Newswire
Investors who lost money on ESSA Pharma Inc.(EPIX) should contact The Gross Law Firm about pending Class Action - EPIX
Investors who lost money on ESSA Pharma Inc.(EPIX) should contact The Gross Law Firm about pending Class Action - EPIX PR Newswire
18.02.25 - PR Newswire
ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EPIX
ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EPIX PR Newswire
16.02.25 - PR Newswire
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit PR Newswire
14.02.25 - PR Newswire
Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX
Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX PR Newswire
13.02.25 - PR Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma PR Newswire
13.02.25 - PR Newswire
Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for Investors - Contact The Gross Law Firm
Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire
11.02.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIX
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIX PR Newswire
11.02.25 - PR Newswire
ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024
ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024 PR Newswire
11.02.25 - PR Newswire
ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EPIX
ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EPIX PR Newswire
10.02.25 - PR Newswire
Class Action Filed Against ESSA Pharma Inc. (EPIX) - March 25, 2025 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against ESSA Pharma Inc. (EPIX) - March 25, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire
07.02.25 - PR Newswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit ...
04.02.25 - PR Newswire
Shareholder Rights Law Firm Robbins LLP Urges EPIX Shareholders with Large Losses to Seek Counsel for the ESSA Pharma Inc. Class Action
Shareholder Rights Law Firm Robbins LLP Urges EPIX Shareholders with Large Losses to Seek Counsel for the ESSA Pharma Inc. Class Action PR Newswire
04.02.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIX
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIX PR Newswire
03.02.25 - PR Newswire
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +2,17%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »